MarketScreener Strategies Immatics N.V.

Stocks

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-10 pm EDT			5-day change	1st Jan Change
9.680 ^USD	-2.81%		-2.71%	-7.81%

Jun. 01	Immatics N.V. Announces Updated Clinical Data For IMA203CD8, IMA401, And Anzu-Cel PRAME Cell Therapies	CI
Jun. 01	Immatics Presents Clinical Activity and Response Dynamics of Anzu-Cel Prame Cell Therapy At 2026 Asco Annual Meeting	CI

No results match your criteria